1. Rising Prevalence of Cancer Cases Is One of the Foremost Factors Driving the Circulating Tumor Cells Market

There is an increased demand for high detection and enrichment methods for CTCs in the routine clinical analysis, and during and after the chemotherapy methods for a range of cancer types, such as lung cancer, gastric cancer, and breast cancer, among others. The increasing prevalence of cancer has a direct impact on the growth of the CTC Market. Lung cancer and breast cancer are among the most common types of cancer in the world, predominantly in the European and Asian countries. Additionally, a majority of multinational players are highly investing in the search for better biomarkers that are to be made available to the larger population. Thus, increasing awareness, the rise in disposable income, and growing global reach of top companies in healthcare primarily drive the Circulating Tumor Cells Market.

2. Single Spiral Micro Channel is Expected to Register a Large Market Segment

The spiral microchannel identifies and addresses the key challenges to the next generation CTCs isolation assay with high sensitivity, separate antibody isolation, and high throughput. Advancement in technology is also being experimented with considerable success rate by several companies. The companies have also been successful in scaling up the separation process through other channel geometries and parallelization. Thus, the forecast period is expected to show a high growth in the market share for this sub-segment.

Speak to our Research Analyst to know more about the latest Market Trends and Market Dynamics

3 The Asia-Pacific Region is Expected to Witness Fastest Growth in the Forecast Period

The Asia Pacific region is expected to show a higher rate of growth opportunities, with the increase in the policies for chronic diagnosis, increasing aid for the early detection of diseases, improving disposable incomes, and raising awareness among the public in countries, such as China, Japan, Korea, Malaysia, and India. The vast diverse patient pool and increase in the number of suppliers in each country help drive the growth of this market. Although, according to the World Health Organization, a sharp increase in healthcare costs is expected in this region owing to the growing population in urban societies. This, in turn, would have a negative impact on cancer diagnostics among the larger section of the population that is surviving with very fewer wages. The North American region, on the other hand, is expected to maintain the largest market share due to well-developed healthcare infrastructure and population reach.

4. Leading Companies to Watch

The report also examines the role of the leading players in the market. Some of the key players listed in the study are:

Advanced Cell Diagnostics Inc.

ApoCell

Aviva Biosciences

Biocept Inc.

CellTraffix Inc.

Clearbridge Biomedics Pte Ltd

Creatv Microtech Inc.

Menarini Silicon Biosystems

Miltenyi Biotec

Qiagen

Access the full report to know more about each Key Player, and its Competition

About the Circulating Tumor Cells Market

As per Mordor Intelligence’s analysis, the Global Circulating Tumor Cells Market is expected to register a CAGR of about 9.0% over the forecast period of 2018-2023, with cancer prevalence, advancement in biomedical imaging and bioengineering technology, and increasing demand for preventive medicine playing pivotal roles in driving the market.

Get the full report from Mordor Intelligence to know more about the Circulating Tumor Cells Market

Mordor Intelligence is a market intelligence and advisory firm operating in 14 industry segments, serving over 600 clients, worldwide.

The post Vital Aspects in the Growth of the Circulating Tumor Cells Market appeared first on Official Blog | Mordor Intelligence.